克莱罗丹型二甲的抗炎和细胞毒性活动
Rubria Marlen Martínez-Casares1, Liliana Hernández-Vázquez1, Angelica Mandujano2
1Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana-Xochimilco, Calzada del Hueso 1100, Coyoacán 04960, CDMX, Mexico.
Molecules (Basel, Switzerland)
|June 28, 2023
概括
克莱罗丹二甲类药物具有显著的细胞毒性和抗炎性质. 这篇评论强调了它们作为抗癌剂的潜力,目前正在进行的研究正在探索新型化合物和治疗应用.
科学领域:
- 自然产品化学 自然产品化学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 克莱罗丹二类是各种植物家族和生物体中发现的二次代谢物.
- 这些化合物以其潜在的生物活性而闻名,包括细胞毒性和抗炎作用.
研究的目的:
- 审查和综合最近 (2015-2023) 关于具有细胞毒性或抗炎活性的克莱罗丹和新克莱罗丹迪特尔类药物的发现.
- 为了识别富含这些生物活性化合物的植物物种和植物家族.
- 探索克勒二甲的抗增殖机制和治疗潜力.
主要方法:
- 在PubMed,Google Scholar和Science Direct中进行全面的文献搜索.
- 使用的关键词:克莱罗丹,新克莱罗丹,细胞毒性,抗炎活性.
- 收录标准:2015年至2023年2月发表的文章.
主要成果:
- 该审查涵盖了18种物种 (7个家族) 的抗炎作用和25种物种 (9个家族) 的细胞毒性活性.
- 占主导地位的植物家族包括Lamiaceae,Salicaceae,Menispermaceae和Euphorbiaceae. 这些植物是主要的植物.
- 克莱罗丹二类药物对各种癌症细胞系表现出活性,已确定具有抗增殖机制.
结论:
- 克莱罗丹二甲类代表具有显著抗癌潜力的有前途的化合物类.
- 进一步研究新的克莱罗丹结构及其特性是有必要的.
- 了解治疗目标可以帮助预测这些二类药物的潜在不良影响.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
177
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
177
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
201
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
201
Antiasthma Drugs: Leukotriene Modifiers
371
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
371
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
158
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
158
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
[4+2] Cycloaddition of Conjugated Dienes: Diels–Alder Reaction
10.3K
The Diels–Alder reaction is an example of a thermal pericyclic reaction between a conjugated diene and an alkene or alkyne, commonly referred to as a dienophile. The reaction involves a concerted movement of six π electrons, four from the diene and two from the dienophile, forming an unsaturated six-membered ring. As a result, these reactions are classified as [4+2] cycloadditions.
10.3K


